IVA Inventiva S.A. - American Depository Shares
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Apr 8, 2026
$3,56
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$3,11rendah 52m
$7,98tinggi 52m
P/E
-2.4
EPS
$-1.90
Pendapatan
$4M
lencana Anda
Rentang 52M
$3–$8
Peringkat Analis
STRONG BUY
Target Harga
$16
P/E
-2.4
ROE
524.0%
Margin Laba Bersih
-7899.6%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
IVA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$3.56
P/E
-2.4
EPS
$-1.90
Pendapatan
$4M
ROE
524.0%
Rentang 52M
$3–$8
IVA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$4M2018-12-31 → 2025-12-31
EPS$-1.902019-12-31 → 2025-12-31
Margin bersih-7899.6%2020-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | IVA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -2.4rata-rata 5T ≈-3.8 | ≈-3.8 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | IVA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Operating Margin (Margin Operasi) | -3145.5%rata-rata 5T ≈-1301.1% | ≈-1301.1% | · | · | |
| EBITDA Margin (Margin EBITDA) | -3145.5%rata-rata 5T ≈-1301.1% | ≈-1301.1% | · | · | |
| Net Profit Margin (Margin Laba Bersih) | -7899.6%rata-rata 5T ≈-2432.7% | ≈-2432.7% | · | · | |
| ROA | -192.2%rata-rata 5T ≈-118.1% | ≈-118.1% | · | · | |
| ROE | 524.0%rata-rata 5T ≈-196.7% | ≈-196.7% | · | · |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | IVA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Current Ratio (Rasio Lancar) | 3.2rata-rata 5T ≈2.7 | ≈2.7 | · | · | |
| Quick Ratio (Rasio Cepat) | 0.2rata-rata 5T ≈1.0 | ≈1.0 | · | · | |
| Interest Coverage (Cakupan Bunga) | -4.2rata-rata 5T ≈-101.5 | ≈-101.5 | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | IVA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0rata-rata 5T ≈0.1 | ≈0.1 | · | · | |
| Receivables Turnover (Perputaran Piutang) | 3.5rata-rata 5T ≈5.6 | ≈5.6 | · | · | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$65.0K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
33.5%
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | $-0.25 | $-0.38 | 33.5% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $9M | $17M | $12M | $4M | $372.0K | $7M | $3M | |
| R&D Expense | $87M | $91M | $110M | $60M | $48M | $24M | $34M | $32M | |
| SG&A Expense | $48M | $16M | $14M | $13M | $11M | $8M | $6M | $6M | |
| Operating Income | $-141M | $-98M | $-103M | $-57M | $-52M | $-30M | $-30M | $-33M | |
| Interest Expense | $34M | $12M | $5M | $584.0K | $138.0K | $66.0K | $3.0K | $4.0K | |
| Interest Income | $4M | $3M | $2M | $5M | $5M | $2M | $175.0K | $142.0K | |
| Income Tax | $22.0K | $313.0K | $607.0K | $-20.0K | $364.0K | $0 | $0 | · | |
| Net Income | $-354M | $-184M | $-110M | $-54M | $-50M | $-34M | $-30M | $-33M | |
| EPS (Basic) | $-1.90 | $-3.08 | $-2.43 | $-1.31 | $-1.27 | $-0.99 | $-1.28 | · | |
| EPS (Diluted) | $-1.90 | $-3.08 | $-2.43 | $-1.31 | $-1.27 | $-0.99 | $-1.28 | · | |
| Shares (Basic) | 186,801,792 | 59,778,701 | 45,351,799 | 41,449,732 | 39,168,152 | 33,874,751 | 23,519,897 | · | |
| Shares (Diluted) | 186,801,792 | 59,778,701 | 45,351,799 | 41,449,732 | 39,168,152 | 33,874,751 | 23,519,897 | 20,540,979 | |
| EBITDA | $-141M | $-98M | $-103M | $-57M | $-52M | $-30M | · | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $26M | $9M | $70M | $44M | $94M | $22M | $15M | |
| Receivables | $2M | $531.0K | $4M | $0 | $4M | · | · | · | |
| Inventory | · | $0 | $417.0K | $373.0K | $392.0K | $320.0K | $387.0K | $410.0K | |
| Current Assets | $244M | $112M | $48M | $106M | $116M | $133M | $49M | $72M | |
| PP&E (Net) | · | $5M | $9M | $7M | $3M | $3M | $4M | $5M | |
| Intangibles | $182.0K | $48.0K | $541.0K | $568.0K | $770.0K | $935.0K | $1M | $2M | |
| Total Assets | $250M | $119M | $70M | $116M | $122M | $139M | $57M | $80M | |
| Accounts Payable | · | $33M | $38M | $19M | $15M | $7M | $7M | · | |
| Current Liabilities | $77M | $121M | $50M | $31M | $23M | $14M | $14M | $15M | |
| Total Liabilities | $278M | $226M | $102M | $71M | $33M | · | · | · | |
| Retained Earnings | · | · | · | · | · | $-34M | $-30M | $-33M | |
| Stockholders' Equity | $-29M | $-107M | $-32M | $45M | $89M | $111M | $41M | $62M |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-105M | $-86M | $-82M | $-45M | $-48M | $-31M | $-28M | $-34M | |
| Investing Cash Flow | $-133M | $9M | $-8M | $9M | $-2M | $-9M | $-826.0K | $-420.0K | |
| Financing Cash Flow | $241M | $146M | $29M | $37M | $25M | $112M | $8M | $32M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3145.5% | -1060.6% | -587.7% | -468.9% | -1242.6% | -7988.7% | · | · | |
| Net Margin | -7899.6% | -2002.7% | -631.8% | -445.6% | -1183.5% | -9037.4% | · | · | |
| EBITDA Margin | -3145.5% | -1060.6% | -587.7% | -468.9% | -1242.6% | -7988.7% | · | · | |
| ROA | -192.2% | -195.4% | -119.0% | -45.6% | -38.0% | -34.3% | · | · | |
| ROE | 524.0% | 265.7% | -1642.8% | -80.8% | -49.6% | -44.1% | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 0.9 | 1.0 | 3.5 | 5.1 | 9.6 | · | · | |
| Quick Ratio | 0.2 | 0.2 | 0.3 | 2.3 | 1.9 | 6.7 | · | · | |
| Interest Coverage | -4.2 | -8.0 | -19.8 | -97.8 | -377.6 | -450.3 | · | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | 3.5 | 4.2 | 9.2 | · | · | · | · | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.02 | $0.15 | $0.39 | $0.29 | $0.11 | $0.01 | · | · | |
| Cash Flow / Share | $-0.56 | $-1.44 | $-1.80 | $-1.08 | $-1.22 | $-0.90 | · | · | |
| EPS (TTM) | $-1.90 | $-3.08 | $-2.43 | $-1.31 | $-1.27 | $-0.99 | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $9M | $17M | $12M | $4M | $372.0K | · | · | |
| Net Income TTM | $-354M | $-184M | $-110M | $-54M | $-50M | $-34M | · | · | |
| P/E | -2.4 | -0.7 | -1.9 | -3.4 | -10.8 | -14.6 | · | · | |
| Earnings Yield | -40.9% | -143.9% | -53.8% | -29.4% | -9.3% | -6.8% | · | · |
Tidak ada pengajuan triwulanan untuk IVA
Kami belum memiliki pengajuan SEC untuk ticker ini.
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $4M | $9M | $17M | $12M | $4M |
| Margin Operasi % | -3145.5% | -1060.6% | -587.7% | -468.9% | -1242.6% |
| Laba Bersih | $-354M | $-184M | $-110M | $-54M | $-50M |
| EPS Dilusian | $-1.90 | $-3.08 | $-2.43 | $-1.31 | $-1.27 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 3.2 | 0.9 | 1.0 | 3.5 | 5.1 |
| Rasio Cepat | 0.2 | 0.2 | 0.3 | 2.3 | 1.9 |
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Pemilik institusional (13F) 89 pengaju · $328.6M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
89
Nilai yang dipegang
$328.6M
Posisi baru
32
Posisi yang keluar
7
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 32 (+9 vs Kuartal sebelumnya) | 7 (-4 vs Kuartal sebelumnya) | 35 (+16 vs Kuartal sebelumnya) | 7 (-3 vs Kuartal sebelumnya) | +33.1M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Caligan Partners LP | $30.856.862 | 8.163.191 | 9,39% | Saham |
| SAMSARA BIOCAPITAL, LLC | $23.869.963 | 6.314.805 | 7,26% | Saham |
| Paradigm Biocapital Advisors LP | $15.120.000 | 4.000.000 | 4,60% | Saham |
| ANDERA PARTNERS | $13.733.424 | 3.633.181 | 4,18% | Saham |
| ADAR1 Capital Management, LLC | $13.633.160 | 3.606.656 | 4,15% | Saham |
| MILLENNIUM MANAGEMENT LLC | $13.276.018 | 3.512.174 | 4,04% | Saham |
| SymBiosis Capital Partners, LLC | $13.064.700 | 2.354.000 | 3,98% | Saham |
| Nantahala Capital Management, LLC | $10.154.566 | 2.686.393 | 3,09% | Saham |
| Trails Edge Capital Partners, LP | $10.047.228 | 2.657.997 | 3,06% | Saham |
| FRANKLIN RESOURCES INC | $9.989.070 | 2.642.611 | 3,04% | Saham |
| Squadron Capital Management LLC | $9.204.300 | 2.435.000 | 2,80% | Saham |
| Woodline Partners LP | $8.781.503 | 2.323.149 | 2,67% | Saham |
| Aberdeen Group plc | $8.723.382 | 2.307.773 | 2,65% | Saham |
| UBS Group AG | $8.713.626 | 2.305.192 | 2,65% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $7.574.296 | 2.003.782 | 2,30% | Saham |
| Patient Square Capital LP | $7.435.906 | 1.967.171 | 2,26% | Saham |
| NEXTBio Capital Management LP | $6.758.580 | 1.787.984 | 2,06% | Saham |
| CITADEL ADVISORS LLC | $6.745.659 | 1.784.566 | 2,05% | Saham |
| AMERIPRISE FINANCIAL INC | $6.415.219 | 1.697.148 | 1,95% | Saham |
| Point72 Asset Management, L.P. | $6.361.785 | 1.683.012 | 1,94% | Saham |
| Integral Health Asset Management, LLC | $5.745.600 | 1.520.000 | 1,75% | Saham |
| Yu Fan | $5.670.000 | 1.500.000 | 1,73% | Saham |
| NEA Management Company, LLC | $5.528.575 | 1.462.586 | 1,68% | Saham |
| STEMPOINT CAPITAL LP | $5.391.490 | 1.426.320 | 1,64% | Saham |
| Propel Bio Management, LLC | $4.842.981 | 1.281.212 | 1,47% | Saham |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $4.800.600 | 1.270.000 | 1,46% | Saham |
| JPMORGAN CHASE & CO | $4.647.305 | 1.309.100 | 1,41% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.233.600 | 1.120.000 | 1,29% | Saham |
| Ikarian Capital, LLC | $4.152.521 | 1.129.101 | 1,26% | Saham |
| Polar Capital Holdings Plc | $4.060.529 | 1.074.214 | 1,24% | Saham |
| MARSHALL WACE, LLP | $3.651.131 | 965.907 | 1,11% | Saham |
| Alyeska Investment Group, L.P. | $3.436.020 | 909.000 | 1,05% | Saham |
| MORGAN STANLEY | $3.408.199 | 901.640 | 1,04% | Saham |
| JANE STREET GROUP, LLC | $3.407.175 | 901.369 | 1,04% | Saham |
| HighVista Strategies LLC | $3.142.851 | 831.442 | 0,96% | Saham |
| Deep Track Capital, LP | $3.024.000 | 800.000 | 0,92% | Saham |
| TWO SIGMA INVESTMENTS, LP | $2.752.260 | 728.111 | 0,84% | Saham |
| DIADEMA PARTNERS LP | $2.725.718 | 740.786 | 0,83% | Saham |
| BVF INC/IL | $2.593.231 | 686.040 | 0,79% | Saham |
| FMR LLC | $2.590.812 | 685.400 | 0,79% | Saham |
| Ally Bridge Group (NY) LLC | $2.399.544 | 634.800 | 0,73% | Saham |
| Qube Research & Technologies Ltd | $1.502.769 | 397.558 | 0,46% | Saham |
| J. Goldman & Co LP | $1.275.750 | 337.500 | 0,39% | Saham |
| Simplify Asset Management Inc. | $1.184.966 | 313.483 | 0,36% | Saham |
| Artisan Partners Limited Partnership | $996.174 | 263.538 | 0,30% | Saham |
| Ghisallo Capital Management LLC | $945.000 | 250.000 | 0,29% | Saham |
| Burkehill Global Management, LP | $850.500 | 225.000 | 0,26% | Saham |
| SEVEN GRAND MANAGERS, LLC | $850.500 | 225.000 | 0,26% | Saham |
| GOLDMAN SACHS GROUP INC | $848.606 | 224.499 | 0,26% | Saham |
| XTX Topco Ltd | $809.986 | 214.282 | 0,25% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 6 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 0,37% | 33.996 NS | 31 Juli 2026 | N-PORT |
| IEUS · iShares Trust | 0,03% | 10.684 SH | 11 Sep. 2026 | Harian |
| ISCF · iShares Trust | 0,01% | 17.398 SH | 11 Sep. 2026 | Harian |
| SCZ · iShares Trust | 0,01% | 320.867 SH | 11 Sep. 2026 | Harian |
| WSML · iShares Trust | 0,00% | 7.665 SH | 11 Sep. 2026 | Harian |
| IEFA · iShares Trust | 0,00% | 713.349 SH | 11 Sep. 2026 | Harian |
IVA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 17 analis
BELI
Target median
$14.00
+293,3%
8 47,1%
Beli Kuat
8 47,1%
Beli
1 5,9%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
11 analis · 2026-09-29Target rata-rata $15.55 +336,7%
← Di bawah semua target
Harga saat ini $3.56
Rendah$10.00
Rata-rata$15.55
Tinggi$26.00
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 20-F diajukan Apr 8, 2026